Tumor osteolysis in osteopetrotic mice

被引:35
作者
Clohisy, DR
Ogilvie, CM
Ramnaraine, MLR
机构
[1] Department of Orthopaedic Surgery, University of Minnesota, Minneapolis, Minnesota
关键词
D O I
10.1002/jor.1100130613
中图分类号
R826.8 [整形外科学]; R782.2 [口腔颌面部整形外科学]; R726.2 [小儿整形外科学]; R62 [整形外科学(修复外科学)];
学科分类号
摘要
Details of the cellular and biochemical mechanisms involved in focal destruction of bone at sites of tumor osteolysis are unknown. It has been shown that tumors from sarcoma (2472) cell lines induce focal osteolysis in mice by stimulating formation and activation of osteoclasts. In this report, the influence of 2472 tumors on the skeletons of osteoclast-deficient animals (op/op) was studied, After op/op femora had been inoculated with 2472 cells, tumors developed and focal osteolysis occurred. There were more osteoclasts per histologic section in sham-injected femora (19 +/- 5) than in tumor-bearing femora (412 +/- 129) (p < 0.05). The size of the osteoclasts also increased from 304 +/- 81 mu m(2) in sham-injected limbs to 407 +/- 62 mu m(2) in tumor-bearing limbs (p < 0.001). Conditioned media from 2472 op/op tumor explants contained macrophage colony-stimulating factor. A deficiency of osteoclasts in op/op mice is the result of the absence of this factor; therefore, these data introduce the possibility that macrophage colony-stimulating factor derived from 2472 tumor may be responsible for directing osteoclast-mediated osteolysis at sites of the tumor.
引用
收藏
页码:892 / 897
页数:6
相关论文
共 13 条
  • [1] DELAYED HEMATOPOIETIC DEVELOPMENT IN OSTEOPETROTIC (OP/OP) MICE
    BEGG, SK
    RADLEY, JM
    POLLARD, JW
    CHISHOLM, OT
    STANLEY, ER
    BERTONCELLO, I
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1993, 177 (01) : 237 - 242
  • [2] BEGG SK, 1993, EXP HEMATOL, V21, P493
  • [3] CLOHISY DR, 1987, J BIOL CHEM, V262, P15922
  • [4] CLOHISY DR, 1994, J BONE MINER RES S1, V9, P74
  • [5] MACROPHAGE COLONY STIMULATING FACTOR RESTORES INVIVO BONE-RESORPTION IN THE OP/OP OSTEOPETROTIC MOUSE
    FELIX, R
    CECCHINI, MG
    FLEISCH, H
    [J]. ENDOCRINOLOGY, 1990, 127 (05) : 2592 - 2594
  • [6] MACROPHAGE-COLONY-STIMULATING FACTOR STIMULATES SURVIVAL AND CHEMOTACTIC BEHAVIOR IN ISOLATED OSTEOCLASTS
    FULLER, K
    OWENS, JM
    JAGGER, CJ
    WILSON, A
    MOSS, R
    CHAMBERS, TJ
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1993, 178 (05) : 1733 - 1744
  • [7] HUMAN MACROPHAGE COLONY-STIMULATING FACTOR INHIBITS BONE-RESORPTION BY OSTEOCLASTS DISAGGREGATED FROM RAT BONE
    HATTERSLEY, G
    DOREY, E
    HORTON, MA
    CHAMBERS, TJ
    [J]. JOURNAL OF CELLULAR PHYSIOLOGY, 1988, 137 (01) : 199 - 203
  • [8] CONGENITAL OSTEOCLAST DEFICIENCY IN OSTEOPETROTIC (OP/OP) MICE IS CURED BY INJECTIONS OF MACROPHAGE COLONY-STIMULATING FACTOR
    KODAMA, H
    YAMASAKI, A
    NOSE, M
    NIIDA, S
    OHGAME, Y
    ABE, M
    KUMEGAWA, M
    SUDA, T
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1991, 173 (01) : 269 - 272
  • [9] OSTEOPETROSIS, A NEW RECESSIVE SKELETAL MUTATION ON CHROMOSOME 12 OF MOUSE
    MARKS, SC
    LANE, PW
    [J]. JOURNAL OF HEREDITY, 1976, 67 (01) : 11 - 18
  • [10] MUNDY GR, 1984, NEW ENGL J MED, V310, P1718